Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
Clinical trial NCT03748823 · COMPLETED
Trial details
- NCT number
- NCT03748823
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2021-02-02
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.